Ani Pharmaceuticals (ANIP) Reports Q4 EPS of $0.35

February 18, 2014 8:32 AM EST Send to a Friend

Ani Pharmaceuticals (NASDAQ: ANIP) reported Q4 EPS of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Ani Pharmaceuticals (ANIP) Reports Q4 EPS of $0.35

Member Login

Free News Feed